glp-1 drug market competition 2025 Receptor Agonist Size and Strategies To 2035 GLP-1 2.0: Where the Next
Description
It could file for FDA approval as early as this year
in: PubMed | Google Scholar | 1 Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Ontario, Canada
This raises the question of whether other payers will stop coverage and follow suit
In her practice, Dushay has seen some patients develop or exacerbate eating disorders while taking the medications
